
Apellis Pharmaceuticals Inc
NASDAQ:APLS

Intrinsic Value
The intrinsic value of one
APLS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 17.69 USD,
Apellis Pharmaceuticals Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Apellis Pharmaceuticals Inc
APLS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if APLS is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis


Revenue & Expenses Breakdown
Apellis Pharmaceuticals Inc
Balance Sheet Decomposition
Apellis Pharmaceuticals Inc
Current Assets | 727.7m |
Cash & Short-Term Investments | 358.4m |
Receivables | 244.4m |
Other Current Assets | 124.9m |
Non-Current Assets | 79.6m |
PP&E | 17.8m |
Other Non-Current Assets | 61.8m |
Free Cash Flow Analysis
Apellis Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Apellis Pharmaceuticals Inc
Revenue
|
775.8m
USD
|
Cost of Revenue
|
-131.9m
USD
|
Gross Profit
|
644m
USD
|
Operating Expenses
|
-830.2m
USD
|
Operating Income
|
-186.2m
USD
|
Other Expenses
|
-37.5m
USD
|
Net Income
|
-223.7m
USD
|
APLS Profitability Score
Profitability Due Diligence
Apellis Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Apellis Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
APLS Solvency Score
Solvency Due Diligence
Apellis Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Apellis Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APLS Price Targets Summary
Apellis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
APLS
is 36.08 USD
with a low forecast of 18.18 USD and a high forecast of 63 USD.
Dividends
Current shareholder yield for APLS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
APLS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 17.69 USD,
Apellis Pharmaceuticals Inc
is
hidden
.